REG - Haleon PLC - Director/PDMR Shareholding

HALEONAnnouncement

03/06/2025 16:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250603:nRSC2745La&default-theme=true

RNS Number : 2745L  Haleon PLC  03 June 2025

 

Haleon plc: Director/PDMR Shareholding

 

3 June 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by Persons
Discharging Managerial Responsibilities ("PDMRs").

 

On 2 June 2025, Ed Petter, Chief Corporate Affairs Officer, received the
vesting of the first tranche of an award of Haleon Ordinary Shares under the
Haleon Share Value Plan. The award was granted as part of his remuneration
arrangements upon joining Haleon, to compensate for forfeited incentives from
his previous employment.

 

The award is subject to malus and clawback provisions.

 

Further details are set out in the below notification, made in accordance with
the requirements of The UK Market Abuse Regulations.

 

       1                        Details of the person discharging managerial responsibilities / person closely

                        associated

       a)                       Name                                                             Ed Petter

       2                        Reason for the notification

       a)                       Position/status                                                  Chief Corporate Affairs Officer

       b)                       Initial notification /Amendment                                  Initial Notification

       3                        Details of the issuer, emission allowance market participant, auction

                        platform, auctioneer or auction monitor

       a)                       Name                                                             Haleon plc

       b)                       LEI                                                              549300PSB3WWEODCUP19

       4                        Details of the transaction(s): section to be repeated for (i) each type of

                        instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                                place where transactions have been conducted
       a)                       Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

                                Identification code                                              GB00BMX86B70

       b)                       Nature of the transaction                                        Acquisition of Ordinary Shares in respect of the first vesting of the Haleon

                                                                plc Share Value Plan (Buyout award).

       c)                       Price(s) and volume(s)

                                                                                                                                     Price(s)          Volume(s)
                                                                                                                                     Nil               51,584

       d)                       Aggregated information

                                - Aggregated volume                                              N/A

                                - Price

       e)                       Date of the transaction                                          2 June 2025

       f)                       Place of the transaction                                         Outside a trading venue

 4                              Details of the transaction(s): section to be repeated for (i) each type of

                              instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                                place where transactions have been conducted
 a)                             Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

       Identification code      GB00BMX86B70

 b)                             Nature of the transaction                                        Automatic disposal of Ordinary Shares resulting from Haleon plc Share Value

                                                                Plan (Buyout award) vesting to cover tax liabilities.

 c)                             Price(s) and volume(s)

                                                                                                                   Price(s)          Volume(s)
                                                                                                                   £4.134623         24,305.243108

 d)                             Aggregated information

       - Aggregated volume      N/A

       - Price

 e)                             Date of the transaction                                          2 June 2025

 f)                             Place of the transaction                                         London Stock Exchange (XLON) 

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBSGDLBUGDGUX